Viruses, Vol. 12, Pages 554: Serological Immunity to Smallpox in New South Wales, Australia
Viruses, Vol. 12, Pages 554: Serological Immunity to Smallpox in New South Wales, Australia
Viruses doi: 10.3390/v12050554
Authors:
Valentina Costantino
Mallory J. Trent
John S. Sullivan
Mohana P. Kunasekaran
Richard Gray
Raina MacIntyre
The re-emergence of smallpox is an increasing and legitimate concern due to advances in synthetic biology. Vaccination programs against smallpox using the vaccinia virus vaccine ceased with the eradication of smallpox and, unlike many other countries, Australia did not use mass vaccinations. However, vaccinated migrants contribute to population immunity. Testing for vaccinia antibodies is not routinely performed in Australia, and few opportunities exist to estimate the level of residual population immunity against smallpox. Serological data on population immunity in Australia could inform management plans against a smallpox outbreak. Vaccinia antibodies were measured in 2003 in regular plasmapheresis donors at the Australian Red Cross Blood Service from New South Wales (NSW). The data were analysed to estimate the proportion of Australians in NSW with detectable serological immunity to vaccinia. The primary object of this study was to measure neutralising antibody titres against vaccinia virus. Titre levels in donor samples were determined by plaque reduction assay. To estimate current levels of immunity to smallpox infection, the decline in geometric mean titres (GMT) over time was projected using two values for the antibod...
Source: Viruses - Category: Virology Authors: Valentina Costantino Mallory J. Trent John S. Sullivan Mohana P. Kunasekaran Richard Gray Raina MacIntyre Tags: Article Source Type: research
More News: Allergy & Immunology | Australia Health | Biology | Emergency Medicine | Orthopaedics | Outbreaks | Smallpox | Smallpox Vaccine | Study | Vaccines | Virology | Wales Health